| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 4 and exclusion criteria 6. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | glatiramer acetate (Copaxone®) |
| Formulation | 40 mg/ml solution for injection |
| Reference number | 2885 |
| Indication | Treatment of relapsing forms of multiple sclerosis (MS). Copaxone is not indicated in primary or secondary progressive MS |
| Company | TEVA UK Ltd |
| BNF chapter | Malignant disease & immunosuppression |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 22/07/2015 |